↓ Skip to main content

American Association for Cancer Research

EB1089 inhibits the parathyroid hormone–related protein–enhanced bone metastasis and xenograft growth of human prostate cancer cells

Overview of attention for article published in Molecular Cancer Therapeutics, July 2009
Altmetric Badge

Mentioned by

patent
15 patents

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
26 Mendeley
Title
EB1089 inhibits the parathyroid hormone–related protein–enhanced bone metastasis and xenograft growth of human prostate cancer cells
Published in
Molecular Cancer Therapeutics, July 2009
DOI 10.1158/1535-7163.mct-09-0064
Pubmed ID
Authors

Vandanajay Bhatia, Manjit K. Saini, Xiaoli Shen, Lian X. Bi, Suimin Qiu, Nancy L. Weigel, Miriam Falzon

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 1 4%
Spain 1 4%
Italy 1 4%
Unknown 23 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 35%
Student > Bachelor 3 12%
Student > Master 3 12%
Student > Ph. D. Student 3 12%
Professor > Associate Professor 2 8%
Other 3 12%
Unknown 3 12%
Readers by discipline Count As %
Medicine and Dentistry 7 27%
Agricultural and Biological Sciences 5 19%
Biochemistry, Genetics and Molecular Biology 4 15%
Nursing and Health Professions 1 4%
Psychology 1 4%
Other 1 4%
Unknown 7 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2024.
All research outputs
#7,599,917
of 23,172,045 outputs
Outputs from Molecular Cancer Therapeutics
#1,688
of 3,885 outputs
Outputs of similar age
#37,480
of 111,068 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#30
of 72 outputs
Altmetric has tracked 23,172,045 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,885 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 111,068 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.